01 5Belsomra
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 328
2019 Revenue in Millions : 306
Growth (%) : 7
Main Therapeutic Indication : Sleep
Currency : USD
2021 Revenue in Millions : 318
2020 Revenue in Millions : 328
Growth (%) : -3
Main Therapeutic Indication : Sleep
Currency : USD
2022 Revenue in Millions : 258
2021 Revenue in Millions : 318
Growth (%) : -19
Main Therapeutic Indication : Sleep
Currency : USD
2023 Revenue in Millions : 231
2022 Revenue in Millions : 258
Growth (%) : -10
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 306
2018 Revenue in Millions : 260
Growth (%) : 18
LOOKING FOR A SUPPLIER?